VanEck ETF Trust - VanEck Biotech ETF (SNSE:BBH) - Stock Price, News & Analysis

BBH Stock Overview

An exchange traded fund launched and managed by Van Eck Associates Corporation.

BBH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

VanEck ETF Trust - VanEck Biotech ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for VanEck ETF Trust - VanEck Biotech ETF
Historical stock prices
Current Share Price	US$161.83
52 Week High	US$163.65
52 Week Low	US$160.70
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	-0.28%
3 Year Change	-10.68%
5 Year Change	35.68%
Change since IPO	18.20%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BBH	CL Capital Markets	CL Market
7D	0%	0.2%	-0.3%
1Y	-0.3%	9.9%	17.6%

Return vs Industry: BBH underperformed the CL Capital Markets industry which returned 9.9% over the past year.

Return vs Market: BBH underperformed the CL Market which returned 17.6% over the past year.

Price Volatility

Is BBH's price volatile compared to industry and market?
BBH volatility
BBH Average Weekly Movement	0%
Capital Markets Industry Average Movement	3.1%
Market Average Movement	3.1%
10% most volatile stocks in CL Market	5.3%
10% least volatile stocks in CL Market	1.2%

Stable Share Price: BBH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BBH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	n/a	n/a	www.vaneck.com/us/en/investments/biotech-etf-bbh/

VanEck ETF Trust - VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors.

VanEck ETF Trust - VanEck Biotech ETF Fundamentals Summary

How do VanEck ETF Trust - VanEck Biotech ETF's earnings and revenue compare to its market cap?
BBH fundamental statistics
Market cap	US$441.99m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is BBH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BBH income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did BBH perform over the long term?

See historical performance and comparison